Is UNII-87LA6FU830 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-87LA6FU830? Is UNII-87LA6FU830 safe for nursing mother and child? Does UNII-87LA6FU830 extracts into breast milk? Does UNII-87LA6FU830 has any long term or short term side effects on infants? Can UNII-87LA6FU830 influence milk supply or can UNII-87LA6FU830 decrease milk supply in lactating mothers?
Answer by DrLact: About UNII-87LA6FU830 usage in lactation
No information is available on the clinical use of UNII-87LA6FU830 during breastfeeding. If UNII-87LA6FU830 is required by the mother, it is not a reason to discontinue breastfeeding.[1] However, until more data become available, UNII-87LA6FU830 should be used with caution during breastfeeding and an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[2] The manufacturer recommends that breastfeeding be discontinued during UNII-87LA6FU830 therapy and for 18 hours after the last dose of Xeljanz or 36 hours after the last dose of Xeljanz XR.
Alternate Drugs
Tocilizumab(Low Risk)
Methotrexate(Low Risk)
Anakinra(Low Risk)
Infliximab(Safe)
Abatacept(Low Risk)
Sulfasalazine(Safe)
Rituximab(Low Risk)
Hydroxychloroquine(Safe)
Chloroquine(Safe)
Penicillamine(Low Risk)
Etanercept(Safe)
Certolizumab Pegol(Safe)
Auranofin(Low Risk)
Adalimumab(Safe)
Leflunomide(Dangerous)
Dasatinib(Unsafe)
Allopurinol(Safe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)